A persistent PSA level following radical prostatectomy for prostate cancer is associated with a worse prognosis

T he National Comprehensive Cancer Network (NCCN) recently published significant updates specific to treatment options for patients with newly diagnosed multiple myeloma (MM) who are eligible or ineligible for hematopoietic cell transplantation (HCT), recommendations for maintenance therapy, and treatment options for previously treated MM. 1 Based on the most recent clinical evidence, the recommendations are meant to serve as guidelines, and clinicians are encouraged to use their best judgment when applying the recommendations in the context of individual clinical circumstances.